WO2002092853A1 - Detection of spore forming bacteria - Google Patents
Detection of spore forming bacteria Download PDFInfo
- Publication number
- WO2002092853A1 WO2002092853A1 PCT/US2001/015793 US0115793W WO02092853A1 WO 2002092853 A1 WO2002092853 A1 WO 2002092853A1 US 0115793 W US0115793 W US 0115793W WO 02092853 A1 WO02092853 A1 WO 02092853A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- seq
- spore forming
- forming bacteria
- probe
- bacillus
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
Definitions
- This invention relates to methods for the detection of spore forming bacteria.
- the invention is particularly useful in detecting bacteria in paper products and paper manufacturing streams.
- Detection of spore forming bacteria according to the present invention includes methods involving polymerase chain reaction. Primers particularly suitable for use in detection of spore forming bacteria are disclosed as well.
- Paper products used in the packaging of food should be free from the presence of microorganisms which adversely affect the hygiene of the food.
- the most common route of contamination by these microorganisms is during the manufacturing of the paper products, where the microorganisms can grow and flourish. Commonly, such contamination is dealt with through the use of biocides or heat.
- biocide usage may be limited by risks at both the paper mill, and in the final paper product. Additionally, some microorganisms are able to avoid eradication by their inherent protection mechanism - sporulation.
- SFB spore forming bacteria
- SFB can pass through dryer sections of a mill to pose a contamination threat when the paper product is used, for example, in food packaging.
- spore forming bacteria are frequently resistant to all but the most toxic of biocides.
- a number of SFB have been identified as problematic in papermaking, and have been described by Pirttijarvi and others in Journal of Applied Bacteriology 81, 445-458 (1996), the entire contents of which are hereby incorporated by reference.
- the need to rapidly detect spore forming bacteria is not limited to paper making processes.
- the heat resistant spores formed by members of Bacillus, Paenbacillus, and Clostridium can be problematic in food, pharmaceutical, and medical product processing, where heat sterilization under pressure is not appropriate. In these processes, special care must be taken to avoid contamination and to evaluate sources of contamination when present. A rapid identification of a contaminating source material can often prevent unnecessary production stoppages, and may save thousands of dollars.
- the need to identify spore forming bacteria also arises in medical treatment. Occasionally, for example, in the treatment of a bacterial infection, e.g., bronchitis, upper respiratory tract infection, earache, etc., the antibiotic selected is effective against the organism causing the infection but fails to kill a population of bacteria such as a Clostridium strain (a spore forming bacteria). While the Clostridium is normally not problematic, in the absence of competition from other organisms (which are killed by the original course of antibiotics), the Clostridium thrives, causing a potentially serious infection. Thus, there is a need for detecting the presence of such species in a biological sample.
- a bacterial infection e.g., bronchitis, upper respiratory tract infection, earache, etc.
- the antibiotic selected is effective against the organism causing the infection but fails to kill a population of bacteria such as a Clostridium strain (a spore forming bacteria). While the Clostridium is normally not problematic, in the absence of competition from other
- the present invention is directed to methods for detecting the presence of bacteria.
- the present invention is directed to methods for detecting the presence of bacteria using nucleotide primers and probes.
- the present invention is directed to detecting spore forming bacteria with such primers.
- Detection methods according to the present invention include the use of polymerase chain reaction in conjunction with electrophoresis, or fluorescence techniques.
- the present invention is further directed to nucleotide primers, and more particularly, to sets of nucleotide primers, which are used in the detection of spore forming bacteria.
- Spore forming bacteria include, but are not limited to, Bacillus megaterium, Bacillus lichenformis, Bacillus cereus group, Bacillus pumilus, as well as Paenbacillus macerans, Paenbacillus polymyxa, Paenbacillus pabuli, Bacillus flexus, Bacillus subtilis, Bacillus anthracis, Bacillus sporothermodurans, Bacillus sphaericus, Clostridium perfringens, Clostridium butyricum, Clostridium pasteurianum, Clostridium cochlearium, Clostridium scatologenes, Clostridium sordellii, Clostridium lituseburense, Clostridium paradoxum, Clostridium thermocellum
- Amplifying may include the use of polymerase chain reaction, and detecting may include electrophoresing the amplification product and visualizing an electrophoresis substrate with staining.
- the electrophoresis substrate comprises agarose gel; in some embodiments, staining comprises applying ethidium bromide.
- Another aspect of the present invention includes a primer pair comprising a member selected from the group consisting of SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, SEQ ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 7, and SEQ ID NO. 8, and another aspect of the present invention includes a nucleotide sequence, which may be a primer or probe, comprising a sequence selected from the group consisting of SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, SEQ ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 7, and SEQ ID NO. 8.
- the present invention also includes primers selected from the group consisting of SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, SEQ ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 7, and SEQ ID NO. 8.
- the present invention is still further directed to a composition
- a composition comprising at least one cellulose-containing material and at least one primer comprising a sequence selected from the group consisting of SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, SEQ ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 7, and SEQ ID NO. 8.
- the cellulose-containing material may comprise paper pulp.
- kits for testing for the presence of spore forming bacteria comprising at least one primer comprising a sequence selected from the group consisting of SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, SEQ ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 7, and SEQ ID NO.
- kits may be designed for use in testing paper-making processes, or may be generic to testing any material. Methods of using such kits are also within the scope of the present invention.
- the present invention is still further directed to methods for testing a sample for the presence of spore forming bacteria.
- One method comprises a) combining at least two nucleotide primers with a sample, wherein said nucleotide primers i) are complimentary to at least one forward and at least one reverse nucleic acid sequence from the total cellular DNA of the bacteria, ii) are able to hybridize spoOA gene conserved regions of spore forming bacteria, but not those of non-spore forming bacteria, and iii) are such that amplification of a portion of the spoOA gene from cellular DNA of such spore forming bacteria using such primers results in the generation of a 346-365 nucleotide long DNA product; b) amplifying cellular DNA of bacteria in the sample with primers; and c) detecting the presence of amplified DNA.
- the sample may be a cellulose-containing sample and may be a sample taken from a paper making process.
- samples include, but are not limited to, samples from white water, head box, broke, additive storage tank, and coated calender.
- Other samples include air, soil, water, blood, fecal matter, starch, protein, or an epichlorohydrin reaction product.
- Any of the nucleotide sequences disclosed in the present application may be used for the primer pairs, and such sequences include SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, SEQ ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 7, and SEQ ID NO. 8.
- the present invention also provides methods for testing cellulose-containing samples for the presence of spore forming bacteria, wherein the methods comprise combining at least one primer comprising a sequence selected from the group consisting of SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, SEQ ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 7, and SEQ ID NO. 8 with a cellulose-containing sample.
- the present invention is also directed to methods for testing a cellulose-containing sample for the presence of spore forming bacteria.
- One such method comprises a) combining at least two nucleic acid primers of the invention, complimentary to at least one forward and at least one reverse nucleic acid sequence from the total cellular DNA of the bacteria with a cellulose-containing sample; and b) visualizing hybridized primers.
- the at least two nucleic acid primers preferably comprise at least one of SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, SEQ ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 7, and SEQ ID NO. 8.
- the present invention also provides methods for controlling a population of spore forming bacteria in an industrial process stream, the methods comprising a) detecting bacteria in the process stream using a primer comprising a sequence selected from the group consisting of SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, SEQ ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 7, and SEQ ID NO. 8; and b) adjusting a biocide concentration in the process stream sufficient to reduce the number of bacteria.
- the industrial process stream may be, for example, a paper making process stream, or a food processing stream.
- aspects of the present invention include methods for the systematic identification of sporulation genes in spore forming bacteria, the methods comprising: a) amplifying a portion of a gene from total cellular DNA of the spore forming bacteria by using at least one of SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, SEQ ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 7, and SEQ ID NO. 8; and b) detecting the presence of an amplification product.
- this invention provides a probe for detecting the presence of spore forming bacteria in a sample, the probe comprising a nucleic acid sequence able to form a detectable hybrid with highly conserved regions of the spoOA gene of the spore forming bacteria Bacillus and Clostridium bacteria species set out in either (a) or (b) below: a) Bacillus cereus, Bacillus megaterium, Bacillus anthracis, and Clostridium pasteurianum; b) Bacillus cereus, Bacillus megaterium, Bacillus sphaericus, and
- Clostridium pasteurianum said nucleic acid sequence being unable to form a detectable hybrid with genetic material of non-spore forming bacteria.
- Preferred highly conserved regions of the spore forming bacterium species set out in (a) and (b) are those shown in Table II and Table III of Example 2 herein below.
- Preferred probes of this aspect of the invention are those wherein amplification of a portion of the spoOA gene from the cellular DNA of a spore forming bacteria by a polymerase chain reaction using such probe as one member of a primer set results in the generation of a detectable 346-365 nucleotide long DNA product.
- Additional preferred Bacillus and Clostridium bacteria species for (a) above are Bacillus subtilis and Clostridium thermoaceticum.
- Additional preferred Bacillus and Clostridium bacteria species for (b) above are Bacillus stearothermophilus and Clostridium thermoaceticum. Preferred highly conserved regions for these species are also set out in Tables II and III of Example 2 herein below.
- this invention provides a probe for detecting the presence of spore forming bacteria in a sample, the probe comprising a nucleic acid sequence able to form a detectable hybrid with highly conserved regions of the spoOA gene of the spore forming bacteria Bacillus and Clostridium bacteria species set out in either (a) or (b) below: a) Bacillus cereus, Bacillus megaterium, Bacillus subtilis, and Clostridium pasteurianum; b) Bacillus cereus, Bacillus megaterium, Bacillus sphaericus, and Clostridium pasteurianum, said nucleic acid sequence being unable to form a detectable hybrid with genetic material of non-spore forming bacteria.
- Preferred highly conserved regions of the spore forming bacterium species set out in (a) and (b) are those shown in Table NI and Table Nil of Example 3 herein below.
- Preferred probes of this aspect of the invention are those wherein amplification of a portion of the spoOA gene from the cellular D ⁇ A of a spore forming bacteria by a polymerase chain reaction using such probe as one member of a primer set results in the generation of a detectable 346-365 nucleotide long DNA product.
- Additional preferred Bacillus and Clostridium bacteria species for both (a) and (b) above are Bacillus thuringiensis and Clostridium thermoaceticum.
- Preferred highly conserved regions of these species are those set out in Tables VI and Nil of Example 3 herein below.
- the present invention also provides probes for detecting the presence of spore forming bacteria in a sample, the probe comprising a nucleotide sequence able to form a detectable hybrid with spoOA gene of spore forming bacteria and unable to form a detectable hybrid with genetic material of non-spore forming bacteria, wherein the nucleotide sequence consists essentially of adenine, guanine, cytosine, and thymine.
- nucleotide sequences may comprise SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, SEQ ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 7, or SEQ ID NO. 8.
- Another embodiment of the present invention is a probe for detecting the presence of spore forming bacteria in a sample, the probe comprising a nucleotide sequence able to form a detectable hybrid with spoOA gene of spore forming bacteria and unable to form a detectable hybrid with genetic material of non-spore forming bacteria, wherein the nucleotide sequence is able to form a detectable hybrid to bases 76 to 93 of the spoOA gene of Bacillus cereus, corresponding to GenBank accession number gb U09972.
- This nucleotide sequence may comprise SEQ ID NO. 4 and SEQ ID NO. 5.
- the present invention also provides a probe for detecting the presence of spore forming bacteria in a sample, the probe comprising a nucleotide sequence able to form a detectable hybrid with spoOA gene of spore forming bacteria and unable to form a detectable hybrid with genetic material of non-spore forming bacteria, wherein the nucleotide sequence is able to form a detectable hybrid to bases 403 to 422 of the spoOA gene of Bacillus cereus, corresponding to GenBank accession number gb U09972.
- the nucleotide sequence may comprise SEQ ID NO. 3, SEQ ID NO.6 or SEQ ID NO. 7.
- the present invention is also directed to compositions comprising at least one primer comprising a sequence selected from the group consisting of SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, SEQ ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 7, and SEQ ID NO. 8.
- the composition may also include a cellulose-containing material, such as paper pulp.
- aspects of the present invention include methods for testing samples for the presence of spore forming bacteria, the methods comprising a) combining a tagged or labeled probe of the invention with a sample, b) hybridizing the tagged or labeled probe to the target spore forming bacteria spoOA gene, and c) detecting the hybridized product.
- SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, SEQ ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 7, or SEQ ID NO. 8 may used as tagged or labeled probes.
- Samples which may be tested include, but are not limited to, samples of air, soil, water, blood, fecal matter, starch, protein, and/or an epichlorohydrin reaction product.
- probes for detecting the presence of spore forming bacteria in a sample comprising a nucleotide sequence able to form a detectable hybrid with spoOA gene of spore forming bacteria and unable to form a detectable hybrid with genetic material of non-spore forming bacteria, wherein the nucleotide sequence is able to form a detectable hybrid to bases 70 to 427 of the spoOA gene of Bacillus cereus, the nucleotide sequence consisting essentially of guanine, cytosine, adenine, and thymine.
- Another aspect of the present invention includes probes for detecting the presence of spore forming bacteria in a sample, the probes comprising a nucleotide sequence able to form a detectable hybrid with spoOA gene of spore forming bacteria and unable to form a detectable hybrid with genetic material of non-spore forming bacteria, wherein the nucleotide sequence is able to form a detectable hybrid to bases 70 to 427 of the spoOA gene of Bacillus cereus, or to bases 570 to nucleotide 930 of the spoOA gene of Bacillus subtilis (gb Ml 0082).
- Such nucleotide sequence preferably comprise at least one of SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, SEQ ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 7, and SEQ ID NO. 8.
- Preferred probes of the foregoing aspects of the invention are those wherein amplification of a portion of the spoOA gene from the cellular DNA of a spore forming bacteria by a polymerase chain reaction using such probe as one member of a primer set results in the generation of a detectable 346-365 nucleotide long DNA product.
- Another aspect of the present invention includes methods of making nucleotide sequences for detecting the presence of a conserved gene in spore forming bacteria, the methods comprising a) determining conserved regions of the conserved gene from at least two strains of spore forming bacteria; and b) preparing nucleotide sequences able to hybridize to the conserved regions, wherein the nucleotide sequences consist essentially of adenine, guanine, cytosine, and thymine.
- the conserved gene may comprise spoOA, ssp, and/or dpaA/B, but is preferably spoOA.
- the present invention is also directed to systems for identifying spore forming bacteria, the systems comprising: a) means for rendering DNA of the spore forming bacteria susceptible to hybridization with at least one nucleotide primer; b) at least one nucleotide primer; and c) means for detecting the hybridization of the DNA of the spore forming bacteria to the at least one nucleotide primer.
- the DNA of the spore forming bacteria may comprise the spoOA gene, and the at least one nucleotide primer may consist essentially of adenine, guanine, cytosine, and thymine.
- the at least one nucleotide primer may comprise a sequence selected from the group consisting of SEQ ID NO. 1, SEQ ID NO.
- the means for rendering DNA of the spore forming bacteria susceptible to hybridization may comprise a growth step in which the bacteria are placed in an environment which encourages growth, followed by a lysis step in which the bacteria are lysed.
- the lysis step may comprise heating.
- the means for detecting the hybridization may comprise polymerase chain reaction.
- the means for detecting the hybridization may comprise a fluorescence detection technique.
- the present invention is directed to methods for detecting bacteria, and in particular, spore forming bacteria (SFB).
- Spore forming bacteria are those bacteria which have the ability to form spores, and such bacteria are well known in the art.
- SFB examples include, but are not limited to, Bacillus megaterium, Bacillus lichenformis, Bacillus cereus group, Bacillus pumilus, as well as Paenbacillus macerans, Paenbacillus polymyxa, Paenbacillus pabuli, Bacillus flexus, Bacillus subtilis, Bacillus anthracis, Bacillus sporothermodurans, Bacillus sphaericus, Clostridium perfringens, Clostridium butyricum, Clostridium pasteurianum, Clostridium cochlearium, Clostridium scatologenes, Clostridium sordellii, Clostridium lituseburense, Clostridium paradoxum, Clostridium thermocellum, Thermo anaerobacter brockii, Moorella thermoautotrophica, Sporomusa ovata, Thermobrachium celere, Bacillus acidocaldarus, Bacillus amy
- the present invention is useful in the detection of SFB in paper making processes, but is not limited to such processes.
- paper is to be used in the generic sense. That is, “paper,” as in a “paper making process,” is meant to include paper, paperboard, cardboard, etc.
- the process water itself may be tested.
- the process water may be tested anywhere in the process, but is preferably tested in head boxes or storage tanks.
- Such storage tanks may contain paper making additives which are to be tested for the presence of SFB.
- Such additives include starch, latex, clays, proteins, and epichlorohydrin reaction products, including but not limited to reaction products of poly(adipic acid-co- diethylenetriamine) and epichlorohydrin, sold under the trade name Kimene.
- the paper making machine may be tested for the presence of SFB. Frequently, it is preferable to test shower head deposits for the presence of SFB.
- the present invention may also be used in detecting SFB in air, soil, food, and water, including waste water, industrial process water, and drinking water.
- the present invention may be used in the detection of SFB in protein-containing samples.
- the present invention may be used in the detection of SFB in medical diagnostic applications, including, for example, testing for at least one SFB in blood or fecal matter.
- the methods for detecting bacteria in these other media are similar to those for detection in paper making, as described herein.
- the present invention focuses on the evolutionary conservation of genes mediating the process of sporulation.
- a subset of phylogenetically diverse bacteria are able to form spores. Most commonly found spore forming bacteria are members of the genus Bacillus (aerobic bacteria) and Clostridium (anaerobic bacteria).
- Sporulation is a complicated developmental process, responsive to adverse environmental conditions and under strict physiological control of the cell. Heat, starvation, and chemical perturbation include some but not all of the factors that may induce the sporulation pathway.
- Genes involved early in the sporulation process are highly homologous across species boundaries. SpoOA, one such gene, may be considered a "master switch" in the sporulation process.
- the spoOA gene encodes a kinase responsible for signaling, via phosphorylation, other genes in the process to become active.
- the phosphorylation state of the spoOA kinase dictates its activity in the cell. Due to this central role in triggering sporulation, spoOA is a highly conserved gene and hence a good target gene for detection.
- the present invention is based on the discovery that spore forming bacteria have some conserved genetic material that may be targeted in their detection.
- the conserved genetic material targeted in accordance with the present invention is the spoOA gene, or a gene homologous thereto. By targeting this gene (or a homologous gene), the present invention is able to detect a very broad range of bacteria.
- Each of the bacteria detectable according to the present invention is believed to have the spoOA gene, or a gene homologous thereto, which may be involved in sporulation.
- Other genes which may be targeted in accordance with the present invention include the ssp gene and the dpaA/B gene, each of which is present in sporogenic bacteria and absent in asporogenic bacteria.
- the concept underlying the present invention is the discovery that specific, short chains of nucleotides, can bind to the genetic material of the targeted bacteria. Through a number of different techniques, this binding can be visualized or even quantified.
- the basic underlying technology of the use of nucleic acid probes, or primers, to identify target genetic material is well known in the art, and has been described elsewhere.
- the present invention is directed to the use of nucleotide sequences for targeting specific portions of the spoOA gene.
- nucleotide sequences can bind, or hybridize, to target portions of the SFB genetic material.
- the target portion of the spoOA gene spans bases beginning at about 70 and ending at about 427 of Bacillus cereus, GenBank accession #gb U09972.
- the nucleotide sequences of the present invention can also target homologous sequences from other SFB.
- DNA is composed of two anti-parallel strands composed of nucleotide "bases.” These bases, adenine, guanine, cytosine and thymine, form specific hydrogen bonds with one another. Adenine pairs with thymine and guanine pairs with cytosine. Strands of DNA can be denatured or converted to a single strand form by alkali or heat treatment. When conditions are favorable DNA will reassociate to its double stranded conformation.
- the polymerase chain reaction (Mullis, U. S. Pat. Nos. 4,683,195, 4,683,202, and 4,800,159, the entire contents of each of which is incorporated by reference) is a commonly used method to amplify target DNA segments to detectable levels. It is currently being employed to detect many pathogenic bacteria.
- DNA primers of specific sequence, complementary to flanking regions of the target area are used to prime enzymatic synthesis of DNA using a DNA polymerase.
- DNA polymerase requires a primer to initiate synthesis of a complementary DNA strand.
- a number of different types of apparatuses and systems are available for performing PCR. Common apparatuses include Mini Cycler (MJ Instruments), Delta Cycler I System (EriComp), and Smart Cycler (Cepheid). Other systems may be used in accordance with the present invention as well. Examples are described in U.S. Patent Nos. 5,882,496, 5,674,742, 5,646,039, 5,589,136, 5,639,423, each to NORTHRUP et al., 5,527,510, to ATWOOD et al., and 5,958,349, to PETERSEN et al. For their discussion of PCR systems, U.S. Patent Nos.
- thermostable DNA polymerase isolated from the hyperthermophile Thermus aquaticus, allows for repeated cycles of annealing, polymerization and denaturing to occur without loss of enzymatic activity.
- the process of PCR amplification is a routine laboratory process carried out in automated thermocyling units.
- the result is an exponential amplification of the targeted DNA segment.
- the amplified target may then be detected.
- Preferred primers, primer pairs and primer sets of the invention are those wherein such amplification results in the generation of a detectable 346-365 nucleotide long DNA product.
- the nucleotide sequences of the present invention including SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, SEQ ID NO. 5, SEQ ID NO. 6, SEQ ID NO. 7, and SEQ ID NO. 8., may be used in primers.
- One method for detecting the presence of the amplified product is agarose gel electrophoresis, followed by staining.
- Other detection methods include, but are not limited to, fluorescence detection techniques.
- an intercalating dye such as Syber Green or ethidium bromide binds to double stranded DNA and then fluoresces. Incorporation of these dyes into PCR reactions result in an increase in fluorescence as the PCR reaction proceeds and double stranded DNA is synthesized.
- Thermal denaturation of the generated products can be used to ascertain the size and %GC (%GC is the number of G or C bases divided by the total number of bases) content of the PCR products generated.
- PCR based fluorescent detection system is the TaqManTM system.
- reporter dyes for this system are 6-carboxyfluorescein (FAM), tetra-6-carboxyfluorescein (TET), and hexachloro-6-carboxyfluorescein (HEX).
- FAM 6-carboxyfluorescein
- TET tetra-6-carboxyfluorescein
- HEX hexachloro-6-carboxyfluorescein
- a tagged or labeled nucleotide sequence is used to detect hybridization.
- a fluorescently tagged oligonucleotide sequence derived from an internal region of the spoOA PCR product can be used to detect the presence of the target in samples. As the PCR reaction proceeds the fluorescent tag is cleaved from the probe and fluorescence is observed. Increasing fluorescence is directly correlated with increased target in the test sample. Two examples of such sequences are 5 - AGTATCATTCATGAAATTGG-3 ( SEQ ID NO. 1) and 5 -
- Detection of hybridization between the nucleotide sequences of the present invention and the target may be achieved in a number of manners, in addition to those already mentioned. Especially included in such other methods are those not requiring a polymerase chain reaction or primer pair to obtain a detectable hybrid.
- the nucleotide sequences of the present invention may be tagged or labeled and used to detect the target sequences using oligonucleotide probing.
- the sequences could be tagged or labeled with a fluorescent or radioactive molecule.
- the hybridized nucleotide sequence emits a different energy spectra than in non-hybridized form, which is detected by means well known in the art.
- the hybridized sequence may be detected by autoradiography using exposure to a radiation-susceptible film. See Maniatis, T., E. F.Fritsch and J. Sambrook. 1982 Molecular Cloning: A Laboratory Manual. Cold Spring Harbor
- nucleotide sequences of the present invention including SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3, SEQ ID NO. 4, SEQ ID NO.
- nucleotide sequences of the present invention were generated by sequence comparison of the spoOA gene from a broad spectrum of spore forming bacteria. This process entailed using a nucleic acid sequence alignment software program to elucidate highly conserved regions of the gene. From these regions, specific priming sites were chosen and appropriate primers were synthesized. Determination of the optimal sequences for primer selection is done by trial and error. Preferred primers meet all of the following criteria: i. detection of spoOA from a characterized set of spore forming bacteria; ii. negative results when testing non-SFB; and iii.
- inventive nucleotide sequences disclosed herein are selected based on their ability to hybridize target genes of SFB.
- the instant nucleotide sequences are directed at conserved target genetic material of SFB.
- the instant nucleotide sequences of the present invention should be considered highly preferred.
- absolute identity to the sequences of the present invention may not be necessary to achieve a satisfactory result. That is, it is recognized that substitution of one or more bases may still allow hybridization to the target genes of SFB. Identity to the instant sequences is most preferred, and homologous or conservative substitutions are less preferred, but may still be acceptable.
- spores may be detected at levels as low as 200 spores per gram of paper (and possibly even lower).
- the following steps allow for optimal detection: a. 10 ml of 1% pulp sample (1 g pulp in 100 ml sterile water) is combined with 40 ml of tryptic soy broth medium (Difco Laboratories) and placed at 37 C for 7 hours. b. 4 ml of this sample are spun down to a pellet in a microcentrifuge tube. c. The centrifuged pellet is washed in 100 ⁇ l sterile water (deionized) and centrifuged again. d.
- step a The pellet is resuspended in 30 ⁇ l sterile water and boiled for 5 minutes. e. 5 ⁇ l of the boiled solution is used for PCR and results are visualized on an agarose gel.
- a shorter incubation time in step a) may be used where there are higher concentrations of SFB.
- some samples may require an even longer incubation period in step a). For example, a 16-hour incubation period may be used (but only 1 ml of the sample is centrifuged in step b) for samples that are problematic. For example, longer incubation times may be used where very low numbers of SFB are believed present, or if a PCR amplification inhibitor is present.
- step a) detection to levels as low as approximately 100 spores/g paper may be achieved.
- step a) a process water, additive, or stock sample may be used instead of pulp as the starting sample.
- step e) other visualization methods, e.g., fluorescence methods, may be used.
- EXAMPLE 1 - PRIMER SET NUMBER 1 A set of spoOA sequences is accessed through GenBank and aligned using the CLUSTAL alignment program. From the sequence alignment, oligonucleotide priming sites are selected and a preliminary primer set is chosen. A forward primer, 5 - AAAAAAGCAGTTGACT-3 (SEQ ID NO. 2), and a reverse primer, 5 -
- CGGCTTGCCGTTGTATT-3 (SEQ ID NO. 3), are synthesized. PCR products using this primer set are expected to be in the range of about 300 to 400 base pairs.— PCR reaction conditions are optimized using "Ready to Go" PC R beads (Pharmacia Biotech, Piscataway, NJ.) and different annealing temperatures for the thermocycling program. Any PCR apparatus may be used for this step, and the Mini Cycler and Delta Cycler are non-limiting examples thereof. Characterized SFB, as well as a set of uncharacterized SFB, isolated from a paper mill, are included in this test.
- EXAMPLE 2 - PRIMER SET NUMBER 2 Based on the results of Example 1, above, a second primer set is generated by comparison against a larger data set. TABLE II shows the data considered for the forward primer and TABLE III the data for the reverse primer of the refined primer set.
- This primer set (SEQ ID NOS. 4 and 3) is tested individually against known SFB and non-SFB. This primer set yields spoOA products from characterized SFB and no products from non-SFB. Positive results are indicated by the presence of a band of 346- 365 base pairs in size on an agarose gel, following PCR. TABLE IV shows the results from the characterized SFB which are tested.
- a 100 ml culture of Bacillus cereus is grown to lag phase and then placed at 80 C to induce sporulation.
- This culture is diluted in 10-fold increments in phosphate buffered saline and 0.1 ml of the dilutions are spotted onto 0.5 g paper samples of different types and grades including A) Kraft liner board, recycled, B) alkaline kraft paper, and C) acid fine paper.
- Paper samples are then placed in 10 ml phosphate buffered saline (PBS) and vortexed for 2 minutes.
- PBS phosphate buffered saline
- the samples are then placed at 80 C for 10 minutes and 1 (one) ml of the sample is placed into 9 ml PBS to obtain another 10-fold dilution.
- 0.1 ml of the sample is added to a sterile microfuge tube containing 0.1 ml tryptic soy medium (0.1 ml of the sample and sample dilution are plated to correlate PCR result with colony forming units).
- thermocycler program is set as follows: a. 5 minutes at 94 C b. 30 cycles of: 0.5 minutes at 94 C, 0.5 minutes at 52 C, 0.5 minutes at 72 C c. 3 minutes at 72 C
- A is kraft liner board, recycled
- B is alkaline kraft paper
- C is acid fine paper.
- EXAMPLE 3 - PRIMER SET NUMBER 3 The primer set from Example 2 may inconsistently detect Bacillus sphaericus. In order to address this problem, a new primer set is prepared. The data considered in preparing the refined primer set is shown in TABLE VI (forward primer) and in TABLE VII (reverse primers).
- a new primer set is prepared.
- the new set comprises one forward primer and two reverse primers.
- the new set is: 5 - CAAGAAGATGTGACGAAA-3 (SEQ ID NO. 5) (forward), 5 - GTTGTATTATATTTCTTTGC-3 (SEQ ID NO. 6) (reverse), and 5 - GTTGTGTTAAATTTTTTGGC-3 (SEQ ID NO. 7) (reverse).
- This primer set yields spoOA products from characterized SFB and no products from non-SFB. Positive results are indicated by the presence of a band of 347-356 base pairs in size on an agarose gel, following PCR. TABLE VIII shows the results from the characterized SFB which are tested.
- the pellet is washed in 100 ⁇ l sterile water and centrifuged again.
- the pellet is resuspended in 30 ⁇ l sterile water and boiled for 5 minutes.
- samples A-F are all food-grade packaging board samples of the same type, spiked with different levels of SFB.
- Samples of 10 ml are taken from process water in the head box area of the paper mill. The samples are separately mixed with 40 ml tryptic soy broth medium. Following a 7-hour incubation period, samples are centrifuged to concentrate bacterial contents.
- the supernatant is decanted and the pellet resuspended.
- the resuspended sample is boiled to lyse the bacteria, and the lysed sample cooled and mixed with primers prior to placing the test mixture in a PCR thermocycler.
- thermocycler is run and the PCR results are electrophoresed on an agarose gel, stained with ethydium bromide, and visualized under an ultraviolet light.
- biocide is added to kill the bacteria.
- PROCESS Samples of 10 ml are taken from milk being processed both prior to, and after, pasteurization. Samples are also periodically checked in the packaged product as well.
- Each 10ml sample to be tested is separately mixed with 40 ml tryptic soy broth medium.
- samples are centrifuged to concentrate bacterial contents. The supernatant is decanted and the pellet resuspended.
- the resuspended sample is boiled to lyse the bacteria, and the lysed sample cooled and mixed with primers prior to placing the test mixture in a PCR thermocycler.
- the thermocycler is run and the PCR results are electrophoresed on an agarose gel, stained with ethydium bromide, and visualized under an ultraviolet light. Based upon the results of the testing, appropriate measures may be taken to eradicate the spore forming bacteria at the appropriate stage in the process.
- Samples of 100 mg are taken from fecal matter to be tested. Each lOOmg sample to be tested is separately mixed with 50 ml tryptic soy broth medium. Following a 7- hour incubation period, samples are centrifuged to concentrate bacterial contents. The supernatant is decanted and the pellet resuspended.
- the resuspended sample is boiled to lyse the bacteria, and the lysed sample cooled and mixed with primers prior to placing the test mixture in a PCR thermocycler.
- the thermocycler is run and the PCR results are electrophoresed on an agarose gel, stained with ethydium bromide, and visualized under an ultraviolet light.
- an antibiotic which is effective at treating a spore forming bacterial infection is prescribed.
- contaminants may interfere with the ability of the test method to detect spore forming bacteria.
- the presence of clays, or some enzymes, in a sample may result in an interference with polymerase chain reaction. In such cases, it is recommended that dilution of the original sample be performed until the contaminants are no longer present at an interfering concentration.
- PCR is taught as a method for detecting hybridization of the probes to the target sample, other methods may be used.
- a probe may be linked to a fluorescent (other detectable) molecule prior to mixing with the sample. Upon hybridization, and under the proper conditions, the tagged molecule will give off a detectable energy, e.g., fluorescence.
- inventive nucleotide sequences disclosed herein are selected based on their ability to hybridize target genes of SFB.
- the instant nucleotide sequences are directed at conserved target genetic material of SFB.
- other nucleotide sequences which bind to the target area of SFB genes are within the scope of the present invention.
- inventive nucleotide sequences can be combined with other nucleotide sequences and still achieve the same result. This effect is demonstrated in Examples 1 and 2, where modifying only one of the two primers resulted in improved detection. Thus, it is believed that the combinations of the present inventive nucleotide sequences with other nucleotide sequences is within the scope of the present invention.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR0117012-0A BR0117012A (en) | 2001-05-15 | 2001-05-15 | Detection of spore-forming bacteria |
MXPA03009460A MXPA03009460A (en) | 2001-05-15 | 2001-05-15 | Detection of spore forming bacteria. |
CA002443441A CA2443441A1 (en) | 2001-05-15 | 2001-05-15 | Detection of spore forming bacteria |
CNA018232612A CN1507496A (en) | 2001-05-15 | 2001-05-15 | Detection of spore forming bacteria |
PCT/US2001/015793 WO2002092853A1 (en) | 2001-05-15 | 2001-05-15 | Detection of spore forming bacteria |
EP01939059A EP1390527A1 (en) | 2001-05-15 | 2001-05-15 | Detection of spore forming bacteria |
NO20035082A NO20035082D0 (en) | 2001-05-15 | 2003-11-14 | Detection of spore-forming bacteria |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2001/015793 WO2002092853A1 (en) | 2001-05-15 | 2001-05-15 | Detection of spore forming bacteria |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002092853A1 true WO2002092853A1 (en) | 2002-11-21 |
Family
ID=21742576
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/015793 WO2002092853A1 (en) | 2001-05-15 | 2001-05-15 | Detection of spore forming bacteria |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1390527A1 (en) |
CN (1) | CN1507496A (en) |
BR (1) | BR0117012A (en) |
CA (1) | CA2443441A1 (en) |
MX (1) | MXPA03009460A (en) |
NO (1) | NO20035082D0 (en) |
WO (1) | WO2002092853A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20200340030A1 (en) * | 2017-10-26 | 2020-10-29 | Zhuhai Qiwei Bio-Technology Ltd. | Methods and compositions for assessing and treating intraocular diseases and disorders |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102304559B (en) * | 2010-02-05 | 2013-03-20 | 山东出入境检验检疫局检验检疫技术中心 | Fluorescence quantitative polymerase chain reaction (PCR) method for detecting bacillus coagulans quickly |
WO2019010647A1 (en) * | 2017-07-12 | 2019-01-17 | Ecolab Usa Inc. | A rapid approach for detection of bacterial spores |
CN110592243A (en) * | 2019-09-24 | 2019-12-20 | 湖北广济药业股份有限公司 | Vitamin B2qPCR detection method for residual live bacteria and spores of medium-producing strain, and primers and probes used in method |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996012038A1 (en) * | 1994-10-14 | 1996-04-25 | University Of Wales, Aberystwyth | Method of monitoring endospore-forming bacteria |
US5928875A (en) * | 1998-05-27 | 1999-07-27 | Betzdearborn Inc. | Primers for the detection of spore forming bacteria |
JP2001128698A (en) * | 1999-11-10 | 2001-05-15 | Nippon Beet Sugar Mfg Co Ltd | Method for detecting bacterium of genus clostridium of spore formation type |
-
2001
- 2001-05-15 WO PCT/US2001/015793 patent/WO2002092853A1/en not_active Application Discontinuation
- 2001-05-15 CA CA002443441A patent/CA2443441A1/en not_active Abandoned
- 2001-05-15 EP EP01939059A patent/EP1390527A1/en not_active Withdrawn
- 2001-05-15 BR BR0117012-0A patent/BR0117012A/en not_active IP Right Cessation
- 2001-05-15 MX MXPA03009460A patent/MXPA03009460A/en unknown
- 2001-05-15 CN CNA018232612A patent/CN1507496A/en active Pending
-
2003
- 2003-11-14 NO NO20035082A patent/NO20035082D0/en not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996012038A1 (en) * | 1994-10-14 | 1996-04-25 | University Of Wales, Aberystwyth | Method of monitoring endospore-forming bacteria |
US5928875A (en) * | 1998-05-27 | 1999-07-27 | Betzdearborn Inc. | Primers for the detection of spore forming bacteria |
JP2001128698A (en) * | 1999-11-10 | 2001-05-15 | Nippon Beet Sugar Mfg Co Ltd | Method for detecting bacterium of genus clostridium of spore formation type |
Non-Patent Citations (3)
Title |
---|
BRILL JULIA A ET AL: "Differentiation between spore-forming and asporogenic bacteria using a PCR and Southern hybridization based method.", JOURNAL OF MICROBIOLOGICAL METHODS, vol. 31, no. 1-2, December 1997 (1997-12-01), pages 29 - 36, XP002194200, ISSN: 0167-7012 * |
BROWN D P ET AL: "CHARACTERIZATION OF SPOOA HOMOLOGUES IN DIVERSE BACILLUS AND CLOSTRIDIUM SPECIES IDENTIFIES A PROBABLE DNA-BINDING DOMAIN", MOLECULAR MICROBIOLOGY, BLACKWELL SCIENTIFIC, OXFORD, GB, vol. 14, no. 3, 1994, pages 411 - 426, XP000561540, ISSN: 0950-382X * |
PATENT ABSTRACTS OF JAPAN vol. 2000, no. 22 9 March 2001 (2001-03-09) * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20200340030A1 (en) * | 2017-10-26 | 2020-10-29 | Zhuhai Qiwei Bio-Technology Ltd. | Methods and compositions for assessing and treating intraocular diseases and disorders |
US11746370B2 (en) * | 2017-10-26 | 2023-09-05 | Smilebiotek Zhuhai Limited | Methods and compositions for assessing and treating intraocular diseases and disorders |
Also Published As
Publication number | Publication date |
---|---|
MXPA03009460A (en) | 2004-04-02 |
CN1507496A (en) | 2004-06-23 |
NO20035082D0 (en) | 2003-11-14 |
CA2443441A1 (en) | 2002-11-21 |
EP1390527A1 (en) | 2004-02-25 |
BR0117012A (en) | 2004-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5928875A (en) | Primers for the detection of spore forming bacteria | |
Wilson et al. | Detection of enterotoxigenic Staphylococcus aureus in dried skimmed milk: use of the polymerase chain reaction for amplification and detection of staphylococcal enterotoxin genes entB and entC1 and the thermonuclease gene nuc | |
AU2003303307B2 (en) | Assay and compositions for detection of bacillus anthracis nucleic acid | |
CN102666872A (en) | Detection of nucleic acids in crude matrices | |
Weingart et al. | Comparison of ethylene production by Pseudomonas syringae and Ralstonia solanacearum | |
JP4621919B2 (en) | Multiplex detection method for microorganisms | |
Watterworth et al. | Multiplex PCR-DNA probe assay for the detection of pathogenic Escherichia coli | |
US20040014122A1 (en) | Detection of spore forming bacteria | |
Yoshitomi et al. | Optimization of a 3′-minor groove binder-DNA probe targeting the uidA gene for rapid identification of Escherichia coli O157: H7 using real-time PCR | |
Seale et al. | Thermophilic Spore‐Forming Bacilli in the Dairy Industry | |
US5958686A (en) | Simple PCR technique for detecting and differentiating bacterial pathogens | |
EP1390527A1 (en) | Detection of spore forming bacteria | |
Azokpota et al. | Biodiversity of predominant Bacillus isolated from afitin, iru and sonru at different fermentation time | |
Hashemi et al. | Isolation of Halophilic Bacteria from Maharlu salt Lake-Iran and their evaluation for the production of bioactive compounds | |
AU2001264621A1 (en) | Detection of spore forming bacteria | |
ZA200309723B (en) | Detection of spore forming bacteria. | |
KR20020089391A (en) | Nucleic acid primers of acid-fast bacterium and method of identifying acid-fast bacterium | |
JP7474065B2 (en) | Method for simultaneously detecting multiple bacteria causing spoilage and composition for simultaneously detecting multiple bacteria causing spoilage | |
US8133676B2 (en) | Genetic process for multiplex terminal restriction fragment length polymorphism analysis | |
WO2005083114A1 (en) | Method, kit and system for enhanced nested pcr | |
WO2006116010A2 (en) | Detection of virulence markers of staphylococci | |
US6946267B2 (en) | Method for detecting Staphylococcus aureus | |
KR101113974B1 (en) | Oligonucleotide to be used in determining sporogenous aerobic bacterium and determination method and determination kit for sporogenous aerobic bacerium using the same | |
MXPA00011565A (en) | Primers for the detection of spore forming bacteria in paper products and paper manufacturing streams | |
Škof et al. | REAL‐TIME POLYMERASE CHAIN REACTION FOR DETECTION OF STAPHYLOCOCCUS AUREUS AND PSEUDOMONAS AERUGINOSA IN PHARMACEUTICAL PRODUCTS FOR TOPICAL USE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2443441 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2003/009460 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001264621 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 529392 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001939059 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 018232612 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003/09723 Country of ref document: ZA Ref document number: 200309723 Country of ref document: ZA |
|
WWP | Wipo information: published in national office |
Ref document number: 2001939059 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001939059 Country of ref document: EP |